Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · YATHARTH

YATHARTH

HealthcareHealthcare Services₹10531 cr market cap
₹1078.50 ▼ -1.15% today As of 19 Nov 2026
52-week low ₹550.8052-week high ₹1162.20

-6.1% from the 52-week high · +98.1% above the low

Yatharth Hospital & Trauma Care Services Ltd is a IN-based company operating in industry. The company is headquartered in Greater Noida, Uttar Pradesh. The company went IPO on 2023-08-07. Yatharth Hospital & Trauma Care Services Limited is engaged in the business of providing healthcare services operating hospitals, and other allied services. The company offers facilities, such as amenities, guidelines for admission, visitor policy, helpdesk, and empanelment. The firm provides a spectrum of super specialty services in the field of cardiology, cardiovascular and thoracic surgery, neurology, neurosurgery, urology, nephrology, oncology, gastroenterology and surgical gastroenterology, orthopedics including spine surgery, joint replacement, and sports medicine, plastic and reconstructive surgery, pulmonology, comprehensive mother and childcare including advanced in vitro fertilization. The firm also provides services, such as Dermatology, Ophthalmology, Dentistry, Psychology and Psychiatry, Anesthesiology, Physiotherapy and Rehab, Radiology, Pathology and Laboratory Medicine, and Nutrition and Health. The company has hospitals in Noida, Jhansi, Greater Noida, and Noida Extension.

The short version. YATHARTH reported revenue of ₹431 crore for Sep 2026, up 54.5% from a year earlier. Net profit was ₹51 crore (up 24.4% year on year). Return on equity was 9.4% in Mar 2026. Promoter holding was 55.8% in Sep 2026, down 5.64 points over 8 quarters.

1 · The price

How has the stock traded?

YATHARTH trades 6.1% below its 52-week high and 98.1% above its 52-week low.

Change over period: —

1M+12.4%
3M+28.0%
6M+28.9%
1Y+40.4%

2 · The business

Is it growing?

Sales, year on year+54.5%

Sep 2026 revenue of ₹431 cr.

Profit, year on year+24.4%

Sep 2026 net profit of ₹51 cr.

Net margin11.7%

3.1 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue431393342320279258232219
Net profit5147454541423930
Net margin %11.712.013.114.214.816.316.713.9
EPS (₹)5.254.884.644.714.284.364.023.16

Annual

FY2026FY2025FY2024
Revenue1207880671
Net profit170131114
Net margin %14.114.817.1
EPS (₹)17.6713.5513.33

3 · The quality

How well does it turn capital into profit?

Return on equity was 9.4% in Mar 2026; debt to equity is 0.14.

Profitability · 3 years

Returns and margins

Mar 2026Mar 2025Mar 2024
Return on equity %9.48.113.1
Return on capital %11.010.917.5
EBITDA margin %25.826.428.5
Net margin %13.814.616.7

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.14
Interest cover35.2x
Current ratio3.87
P/E ratio55.6

4 · The owners

Who holds it, and are they adding?

Promoter holding55.8%

Down 5.64 pts over 8 quarters.

Foreign institutions7.05%

Down 2.73 pts over 8 quarters.

Domestic institutions10.94%

Down 0.56 pts over 8 quarters.

Mutual fund schemes24

+6 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter61.4461.6461.6461.6455.855.855.855.8-5.64
FII9.784.454.346.56.185.255.627.05-2.73
DII11.513.5613.528.711.0112.010.8410.94-0.56
Public17.2820.3520.523.1627.0126.9527.7426.21+8.93

Mutual fund holdings · Oct 2026

24 schemes hold this stock

18 the month before.

  • Kotak Healthcare Fund2.68% of NAV
  • LIC MF HEALTHCARE FUND2.16% of NAV
  • Groww BSE Hospitals ETF1.81% of NAV
  • Groww Value Fund1.77% of NAV
  • Kotak Special Opportunities Fund1.59% of NAV
  • UNION ACTIVE MOMENTUM FUND1.35% of NAV
  • Groww Multicap Fund1.23% of NAV
  • Groww Small Cap Fund1.2% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for YATHARTH are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about YATHARTH

What is the YATHARTH share price?

YATHARTH (YATHARTH) last closed at ₹1,078.50, down 1.15% on the day. Its 52-week range is ₹550.80 to ₹1,162.20.

What is the market cap of YATHARTH?

YATHARTH has a market capitalisation of about ₹10,531 crore. Its price-to-earnings ratio is 55.6.

How are YATHARTH's latest results?

YATHARTH reported revenue of ₹431 crore for Sep 2026, up 54.5% from a year earlier. Net profit was ₹51 crore (up 24.4% year on year). Return on equity was 9.4% in Mar 2026. Promoter holding was 55.8% in Sep 2026, down 5.64 points over 8 quarters.

Who owns YATHARTH?

As of Sep 2026, shareholding was: Promoter 55.8%, FII 7.05%, DII 10.94%, Public 26.21%.

How many mutual funds hold YATHARTH?

24 mutual fund schemes held YATHARTH in October 2026. That compares with 18 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.